scholarly article | Q13442814 |
P50 | author | Jooli Han | Q91651249 |
P2093 | author name string | Dennis R Trumble | |
P2860 | cites work | IABP: history-evolution-pathophysiology-indications: what we need to know | Q26739698 |
Adaptive Transcutaneous Power Transfer to Implantable Devices: A State of the Art Review | Q26753025 | ||
The future of left ventricular assist devices | Q26770276 | ||
The total artificial heart | Q26770282 | ||
Left ventricular assist device driveline infections: recent advances and future goals | Q26770293 | ||
Surgical implant techniques of left ventricular assist devices: an overview of acute and durable devices | Q26770313 | ||
New Insights in the Diagnosis and Treatment of Heart Failure | Q26774884 | ||
Temporary mechanical circulatory support: a review of the options, indications, and outcomes | Q26824537 | ||
Mechanical circulatory support for advanced heart failure: patients and technology in evolution | Q26859324 | ||
Advanced therapies for end-stage heart failure | Q26992073 | ||
Left ventricular assist devices as a bridge to cardiac transplantation | Q26999337 | ||
Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant | Q27005729 | ||
Mechanical Circulatory Support for the Failing Heart: Continuous-Flow Left Ventricular Assist Devices | Q28071544 | ||
Left ventricular assist devices-current state and perspectives | Q28074655 | ||
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. | Q30358659 | ||
The Total Artificial Heart in End-Stage Congenital Heart Disease | Q33650322 | ||
Donor selection in heart transplantation | Q34048065 | ||
A changing trend toward destination therapy: are we treating the same patients differently? | Q34240295 | ||
Mechanical circulatory support with the ABIOMED BVS 5000: The Toronto General Hospital experience | Q34338629 | ||
Device-induced ventricular geometric remodeling: appraisal of critical issues | Q34442929 | ||
Gastrointestinal bleed after left ventricular assist device implantation: incidence, management, and prevention | Q34498773 | ||
Present and future perspectives on total artificial hearts | Q34604477 | ||
Durability of continuous-flow left ventricular assist devices: a systematic review | Q34604520 | ||
Direct cardiac compression devices | Q34979710 | ||
Innovative application of immunologic principles in heart transplantation. | Q34986281 | ||
Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation | Q35619854 | ||
Surgical ventricular restoration: technique and outcomes | Q35911436 | ||
Extracorporeal membrane oxygenation (ECMO) for critically ill adults in the emergency department: history, current applications, and future directions. | Q36424722 | ||
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study | Q36534319 | ||
Ventricular assist devices (VAD) therapy: new technology, new hope? | Q36694088 | ||
Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes | Q36776529 | ||
Evolvement of left ventricular assist device: the implications on heart failure management | Q37174283 | ||
Clinical manifestations and management of left ventricular assist device-associated infections. | Q37247231 | ||
Current status of cardiac transplantation and mechanical circulatory support | Q37407716 | ||
Ventricular restraint therapy for heart failure: A review, summary of state of the art, and future directions. | Q51581804 | ||
Miniature intracardiac assist device provides more effective cardiac unloading and circulatory support during severe left heart failure than intraaortic balloon pumping. | Q51616747 | ||
Controversies and Challenges of Ventricular Assist Device Therapy. | Q52632960 | ||
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. | Q52662230 | ||
Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system. | Q53652079 | ||
Controller and battery changes due to technical problems related to the HVAD® left ventricular assist device - a single center experience. | Q55421509 | ||
First successful bridge to cardiac transplantation using direct mechanical ventricular actuation | Q67787693 | ||
Thromboembolic complications of the Jarvik-7 total artificial heart: case report | Q69585548 | ||
Prolonged circulatory support by direct mechanical ventricular assistance | Q72906115 | ||
Recent progress on transcutaneous energy transfer for total artificial heart systems | Q74013561 | ||
Mechanical circulatory assist devices | Q80265068 | ||
Long-term use of the CentriMag® Ventricular Assist System as a right ventricular assist device: a case report | Q82184104 | ||
Cardiac assist with a twist: apical torsion as a means to improve failing heart function | Q82442589 | ||
Ventricular restraint therapy for heart failure: the right ventricle is different from the left ventricle | Q83373778 | ||
A tale of two centrifugal left ventricular assist devices | Q88175758 | ||
HVAD: The ENDURANCE Supplemental Trial | Q90211696 | ||
State of the art: implantable ventricular assist devices | Q37577259 | ||
Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support | Q37837291 | ||
Biventricular assist devices: a technical review. | Q37899081 | ||
Current trends in implantable left ventricular assist devices | Q37913070 | ||
Plutonium-238: an ideal power source for intracorporeal ventricular assist devices? | Q38053865 | ||
Patient selection for ventricular assist devices: a moving target | Q38071757 | ||
Past and present of cardiocirculatory assist devices: a comprehensive critical review. | Q38076112 | ||
Energy transmission and power sources for mechanical circulatory support devices to achieve total implantability | Q38188266 | ||
Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosis. | Q38572789 | ||
Ventricular Assist Device and Destination Therapy Candidates from Preoperative Selection Through End of Hospitalization | Q38633182 | ||
Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom. | Q38790056 | ||
Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure | Q38825553 | ||
Dying With a Left Ventricular Assist Device as Destination Therapy | Q39272546 | ||
Soft robotic sleeve supports heart function | Q40366322 | ||
Minimally invasive approach for percutaneous CentriMag right ventricular assist device support using a single PROTEKDuo Cannula. | Q40589665 | ||
Long-term ventricular wall actuation: can and should it be systematically explored? | Q40995461 | ||
Cardiogenic shock associated with loco-regional anesthesia rescued with left ventricular assist device implantation | Q41255470 | ||
Exercise therapy for an older patient with left ventricular assist device | Q41901870 | ||
Experimental study of combination of extraaortic balloon counterpulsation and ventricular assist cup to acute heart failure in dogs. | Q42549544 | ||
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study | Q43558666 | ||
Postapproval Outcomes: The Berlin Heart EXCOR Pediatric in North America | Q44330529 | ||
Portable pneumatic biventricular driver for the Thoratec ventricular assist device. | Q46118907 | ||
Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support. | Q47578947 | ||
Eighth annual INTERMACS report: Special focus on framing the impact of adverse events | Q47640039 | ||
Left ventricular support with the Impella LP 5.0 for cardiogenic shock following cardiac surgery | Q47750687 | ||
Worldwide surgical experience with the Paracor HeartNet cardiac restraint device | Q47988276 | ||
A muscle-powered energy delivery system and means for chronic in vivo testing | Q50145696 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Destination therapy | Q5265191 |
congestive heart failure | Q19000661 | ||
LVAD | Q15946426 | ||
P304 | page(s) | 18 | |
P577 | publication date | 2019-02-15 | |
P1433 | published in | Bioengineering | Q27727186 |
P1476 | title | Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations | |
P478 | volume | 6 |